3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
4
Melanoma
4
Prostatic Neoplasms
3
Neoplasm Metastasis
3
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Lymphoma
3
Leukemia, Myeloid, Acute
3
Ganglioneuroblastoma
3
Uveal Melanoma
2
Osteosarcoma
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neoplasms, Plasma Cell
1
Lymphoma, T-Cell
1
Lymphoma, Follicular
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Lymphoid
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Erythroblastic, Acute
1
Kidney Neoplasms
1
Interventions
Cisplatin
76
Cetuximab
60
pembrolizumab
56
Radiotherapy, Intensity-Modulated
37
Radiotherapy
33
Carboplatin
31
Docetaxel
30
Fluorouracil
27
Nivolumab
26
Paclitaxel
20
Platinum
10
Albumin-Bound Paclitaxel
9
Surgical Procedures, Operative
8
Radiosurgery
8
Radiation
8
Erlotinib Hydrochloride
8
durvalumab
7
Bevacizumab
7
1,2-diaminocyclohexaneplatinum II citrate
7
epacadostat
6
Biopsy
6
Radiotherapy, Conformal
5
Ipilimumab
5
Immunoglobulin G
5
Gemcitabine
5
Capecitabine
5
130-nm albumin-bound paclitaxel
5
utomilumab
4
tremelimumab
4
palbociclib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Squamous Cell Carcinoma of Head and Neck
×
Colony-Stimulating Factors
×
Clear all
No trials found.